phospho-soda 24,4 g / 10,8 g lösung zum einnehmen
reagila
gedeon richter - cariprazine hydrochloride - schizophrenia - psycholeptics - reagila is indicated for the treatment of schizophrenia in adult patients.
rizmoic
shionogi b.v. - naldemedine tosilate - constipation - drugs for constipation, peripheral opioid receptor antagonists - rizmoic is indicated for the treatment of opioid-induced constipation (oic) in adult patients who have previously been treated with a laxative.
cleenema ready-to-use (21.4g/9.4g)/dose
citrafleet pulver zur herstellung einer lösung zum einnehmen in einem beutel
citrafleet lösung zum einnehmen
phospho-soda
pharmaco (nz) ltd - phosphoric acid 548.22 mg/ml (75%w/w. ho4p2na12h2o & h2o4pna2h2o produced from naoh & phoshoric acid in solution); ; sodium hydroxide 379.33 mg/ml (50%w/w. in solution quantities 240 mg/ml ho4p2na12h2o & 542 mg/ml h2o4pna2h2o); - oral solution - active: phosphoric acid 548.22 mg/ml (75%w/w. ho4p2na12h2o & h2o4pna2h2o produced from naoh & phoshoric acid in solution) sodium hydroxide 379.33 mg/ml (50%w/w. in solution quantities 240 mg/ml ho4p2na12h2o & 542 mg/ml h2o4pna2h2o) excipient: ginger flavour 5741 glycerol purified water saccharin sodium sodium benzoate - for use as part of a bowel cleansing regimen in preparing adult patients from 18 years for colon surgery or for preparing the colon for x-ray or endoscopic examination.
phospho-soda oral solution bottle
chiesi australia pty ltd - dibasic sodium phosphate, quantity: 4.3 g; monobasic sodium phosphate, quantity: 18.8 g - oral liquid - excipient ingredients: glycerol; saccharin sodium; sodium benzoate; purified water; flavour - for use as part of a bowel cleansing regimen in preparing adult patients for colon surgery or for preparing the colon for x-ray or endoscopic examination.
citrafleet powder for oral solution